Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes studyRUTHERFORD, N.J., April 16,…
Investment will accelerate clinical trials and commercialization of Phantom X, with Ottobock joining Phantom Neuro's Board of Directors AUSTIN, Texas,…
IRVINE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the…
IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of…
"Superhuman Body 3D" Explores the Inner Workings of the Human Body and hopes to inspire the next generation of bioengineers…
One-year data for the first patient will be presented for the first time during the SUFU meeting in Palm Springs,…
Company Positioned for Accelerated Growth with Infusion of Capital and Proven Commercial Leadership VALENCIA, Calif., Feb. 20, 2025 /PRNewswire/ --…
IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of…
EOS Aerospace and EOS Earth Divisions to Continue Innovation Legacy Following WiSA Technologies' Strategic Asset Acquisition NEW YORK, Jan. 31,…
TOKYO, Jan. 7, 2025 /PRNewswire/ -- BionicM (CEO: Sunny Xiaojun Sun, Ph.D) is thrilled to announce the launch of its…
